Disclosures for "Case Report: Cerebral Syphilitic Gumma in a Patient with Relapsing-remitting Multiple Sclerosis on Rituximab"
-
An immediate family member of Dr. Moehlman has received research support from NIH.
-
Dr. Ardakani has nothing to disclose.
-
Dr. Crane has nothing to disclose.
-
The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Shah has received personal compensation in the range of $5,000-$9,999 for serving as a Educational Speaker with Rocky Mountain MS Center.